Abstract:Purpose of review: Both traditional and novel cancer therapies can cause cardiovascular toxicity in patients. In vivo models integrating both cardiovascular and cancer phenotypes allow for the study of on- and off-target mechanisms of toxicity arising from these agents. The zebrafish is the optimal whole organism model to screen for cardiotoxicity in a high throughput manner, while simultaneously assessing the role of cardiotoxicity pathways on the cancer therapy's antitumor effect. Here we highlight established zebrafish models of human cardiovascular disease and cancer, the unique advantages of zebrafish to study mechanisms of cancer therapy-associated cardiovascular toxicity, and finally, important limitations to consider when using the zebrafish to study toxicity. Recent findings: Cancer therapy-associated cardiovascular toxicities range from cardiomyopathy with traditional agents to arrhythmias and thrombotic complications associated with newer targeted therapies. The zebrafish can be used to identify novel therapeutic strategies that selectively protect the heart from cancer therapy without affecting antitumor activity. Advances in genome editing technology have enabled the creation of several transgenic zebrafish lines valuable to the study of cardiovascular and cancer pathophysiology. Summary: The high degree of genetic conservation between zebrafish and humans, as well as the ability to recapitulate cardiotoxic phenotypes observed in patients with cancer, make the zebrafish an effective model to study cancer therapy-associated cardiovascular toxicity. Though this model provides several key benefits over existing in vitro and in vivo models, limitations of the zebrafish model include the early developmental stage required for most high-throughput applications.

Zebrafish: Speeding Up the Cancer Drug Discovery Process.

A fresh look at zebrafish from the perspective of cancer research

Zebrafish live imaging: a strong weapon in anticancer drug discovery and development

Zebrafish Xenographs in Oncology and Personalized Medicine

Quo natas, Danio?—Recent Progress in Modeling Cancer in Zebrafish

Zebrafish: a New Model for Anti-Cancer Agents

Zebrafish: An Emerging Model System for Human Disease and Drug Discovery

Fish Tales: the Use of Zebrafish Xenograft Human Cancer Cell Models.

Advantages of the zebrafish tumor xenograft model: the evaluation of efficacy in cancer therapy and the application to the study of lncRNAs

Zebrafish in Lung Cancer Research.

Benefits of Zebrafish Xenograft Models in Cancer Research

Zebrafish patient avatars in cancer biology and precision cancer therapy

Zebrafish xenograft as a tool for the study of colorectal cancer: a review

Zebrafish—A Suitable Model for Rapid Translation of Effective Therapies for Pediatric Cancers

What value do zebrafish have to anticancer drug discovery?

Zebrafish Models of Cancer Therapy-Induced Cardiovascular Toxicity

Zebrafish as tools for drug discovery

Tipping the Scales With Zebrafish to Understand Adaptive Tumor Immunity

Animal models of human disease: zebrafish swim into view

Zebrafish: An emerging model system to study liver diseases and related drug discovery

The Application of Zebrafish Patient‐derived Xenograft Tumor Models in the Development of Antitumor Agents